RIPK3 and cancer: To further address the role of RIPK3 in chemotherapeutic agent-induced cell death, we stably expressed RIPK3 in the RIPK3-negative cancer cell lines HCT116, SW480, and MDA-MB-231 (Figure 5i and Supplementary Figure S2a).